Improving Heart Function (iHF)

Advancing trans-disciplinary innovation in #heartfailure drugs and device solutions to improve patient care.
#ImprovingHeartFunction

[Improving Heart Function (iHF) @iheartfunction]

🫀 New iHF Webinar: “HFrEF & Chronic Coronary Syndromes: from guideline-directed medical therapy to optimal revascularisation strategy”

📅 19 June 2026 | ⏰ 17:30 CET (UTC+2)
👉 Register here: https://t.co/tZ6zlu43EB

Join international experts to explore GDMT optimisation, revascularisation strategies and multidisciplinary decision-making in complex HF patients.

Speakers: @SabineBleiziff2 @MartineGilard @ARakisheva @drbennisahmed @emilianofiorimd Nadya Al Matrooshi

#HFrEF #HeartFailure #Cardiology #GDMT #CardioTwitter #InterventionalCardiology #iHF

[Improving Heart Function (iHF) @iheartfunction]

🫀 When is "early" truly early in mitral regurgitation?

@AlexMebazaa and @SabineBleiziff2 discuss the optimal timing for mitral valve repair and why timely intervention matters for patient outcomes.

Watch the full #iHFCourse2026 session: https://t.co/qCTvedmOia

@EmanueleBarba13 @PhilippLurz @Jolie_Bruno_ @ARakisheva
#Cardiology #HeartFailure #MitralRegurgitation

[Ahmed Bennis MD 🫀 @drbennisahmed]

🫀 How do we optimise care pathways for patients with HFrEF and chronic coronary syndromes in contemporary practice?

📆 Next iHF Webinar: Wednesday 19 June 2026 at 5:30pm (UTC+2)

Join leading international experts for an in-depth discussion on:
https://t.co/6ycGBaNLD6

[Amina @ARakisheva]

Privileged to be part of this discussion alongside outstanding speakers and discussants.
Interested in advancing the care of patients with CAD and HFrEF? Join us as we come together to share knowledge, exchange experiences, and discuss the latest perspectives in patient care.🌍🤍

[PCRonline 🫀 @PCRonline]

Merci beaucoup🙏to everyone who joined us for 4 incredible days of learning & sharing at #EuroPCR, in Paris, and via the Course platform

Thank you to the Course Directors, faculty, LIVE centres, presenters, participants, industry partners, support & AV teams, staff and @ViparisOfficiel - safe travels back home ✈️🚂🚋🚓🚴‍♂️

We are convinced - as you are - that education saves lives, so please mark your calendars for the next edition: 18-21 May 2027.

#interventionalcardiology #KeepOnLearning #Science #Research #CardioEd

[Improving Heart Function (iHF) @iheartfunction]

🔥#EuroPCR 2026 has started - and we’re excited to hear the latest on heart failure!

Members of the iHF Steering Committee and transdisciplinary team will take part in key sessions, sharing their expertise across a wide spectrum of cardiovascular topics.

Full line-up here: https://t.co/VZukmbJfCp

#Cardiology #HeartFailure #CardioEd @AlexMebazaa @EmanueleBarba13

[Improving Heart Function (iHF) @iheartfunction]

𝗶𝗛𝗙 at #EuroPCR 2026!
Join us for the session:
“When to best combine guideline-directed medical therapy and devices at discharge of acute heart failure”
📅 Wed 20 May | 9:45–10:45
📍 Room 243

With @AlexMebazaa, @VranckxPascal and expert discussants, we’ll explore GDMT, CRT, and the benefits of combining therapies and devices at discharge in acute heart failure.
Looking forward to seeing many of you there!
Learn more: https://t.co/kLBjGXnV3Y

#Cardiology #HeartFailure

[Improving Heart Function (iHF) @iheartfunction]

How do you optimise care in patients with aortic stenosis + HFrEF?
In this #iHFCourse replay, multi disciplinary experts discuss how to integrate GDMT and percutaneous valve interventions to improve outcomes.
🎥 Replay available: https://t.co/LVlUwZrmVM
#CardioEd #HeartFailure

[Improving Heart Function (iHF) @iheartfunction]

Atypical #HFrEF: when is the right time to move from GDMT to device therapy?
Christophe Leclercq & @GianluSava share key discussion points from this #iHFCourse session based on a complex clinical case of atypical HFrEF.

Watch the full replay: https://t.co/LnC3VzE7x2
#CardioEd

[Novi Yanti Sari @slumberbell]

30-60% of #HeartFailure patients also have #CKD, & this overlap markedly increases the risk of hospitalization🏥 & death☠️

Despite major advances in each condition, important gaps remain when they coexist⚠️: diagnosis is challenging, biomarkers are harder to interpret, & management is less straightforward

This @goKDIGO executive conclusions brought experts together to tackle these challenges

Here are the key takeaways👇
📄 #JACCHF: https://t.co/MHgmAxAeFX

@JACCJournals @lamcardio @BiykemB @JustinEzekowitz @jardine_meg @jozinetm @HeartDocSadiya @NishaKidneyDoc

[Improving Heart Function (iHF) @iheartfunction]

#ACS complicated by cardiogenic shock remains one of the most critical scenarios in cardiology.
In this #iHFCourse session, the multidisciplinary panel highlights the need for early recognition, rapid stratification & shock team coordination.

Watch 👉 https://t.co/6m17vSBpa0

[Improving Heart Function (iHF) @iheartfunction]

From #PVCs to cardiomyopathy, understanding recovery remains a key clinical challenge.
In this #iHFCourse interview, @ShelleyZieroth and @joselmerino discuss important prognostic factors like ECG features, #PVC morphology and frequency.
Replay session: https://t.co/p4KX2CYG5x

[PCRonline 🫀 @PCRonline]

Join @valeriaparadies for the next #PCRWebinar "Preventing and treating acute heart failure in STEMI patients"
📅 Friday 24 April at 4:00pm (UTC+2)
Register for free: https://t.co/Eijs6Cbu3D
@VPanoulas @sinning_jan

[Improving Heart Function (iHF) @iheartfunction]

🔎 How to find the right time for the right patient regarding mitral regurgitation in #HFrEF?
@AlexMebazaa interviews Michael Boehm about the best indicators for M-TEER and the optimal timing for intervention.
Watch #iHFCourse expert panel discussion:
https://t.co/GnKh4USAUx

[Improving Heart Function (iHF) @iheartfunction]

Treating aortic stenosis goes beyond the valve itself.
In this interview from #iHFCourse 2026, @IUchmanowicz & @S_Raposeiras highlight the need for a holistic approach to address myocardial involvement and HF risk.
🔗 Full session replay: https://t.co/nIK6nyp3dI
#CardioEd #TAVI

[Improving Heart Function (iHF) @iheartfunction]

📊The DARE-AF trial published in @CircAHA explored whether Dapagliflozin, an SGLT2 inhibitor, can reduce AF recurrence post-ablation in patients without typical indications for the drug.

Unlike earlier studies involving patients with conditions like heart failure or type 2 diabetes, this trial focused on 200 patients set for ablation without these comorbidities.

In our Journal Club video, @ShelleyZieroth reviews the findings and their significance for SGLT2 inhibitors in new patient groups.

Watch to learn more about the study design and outcomes⤵️

[Improving Heart Function (iHF) @iheartfunction]

In this interview from the #iHFCourse, @Dr_Owais_Dar Dar and Antoine Kimmoun delve into the crucial role of inotropes in managing cardiogenic shock.

Join us to discover why Dobutamine is considered the primary inodilator for this condition, and gain valuable insights into optimal dosing strategies.

▶️Watch Now: https://t.co/mOyWWjMwIS

[Improving Heart Function (iHF) @iheartfunction]

PVCs in heart failure: what to treat medically, ablate, or leave alone

Ahead of this #iHFCourse session, @DavidDuncker shares a preview of the discussion and the case he will present.

▶️Join us live at 12:15: https://t.co/8RhRsXx51l

[Improving Heart Function (iHF) @iheartfunction]

🔴#IHFCourse 2026 is Live! Join us for an interactive session here or on the website: https://t.co/8RhRsXx51l https://t.co/1Yd6BIrl8c

[Improving Heart Function (iHF) @iheartfunction]

It's the end of Day 1⃣ of #iHFCourse and after an intense couple of hours spent learning & sharing, it's time for a well-deserved moment of relaxation 😊

See you online 📺📱 tomorrow at 08h30 for Day 2!
https://t.co/8RhRsXx51l